Holdings
KVP Capital Advisors, LP
As of Sep 30, 2026, KVP Capital Advisors, LP reported 35 positions worth US$124M. Largest: Praxis Precision Medicines, Inc., Whitehawk Therapeutics, Inc. and Silence Therapeutics PLC. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 42,900 | US$12.5M | no change | Sep 30, 2026 |
| Whitehawk Therapeutics, Inc. | 2.17M | US$8.14M | no change | Sep 30, 2026 |
| Silence Therapeutics PLC | 684K | US$7.48M | new | Sep 30, 2026 |
| Protagonist Therapeutics, Inc. | 53,000 | US$7.47M | no change | Sep 30, 2026 |
| MBX Biosciences, Inc. | 122K | US$7.12M | no change | Sep 30, 2026 |
| Erasca, Inc. | 455K | US$6.67M | no change | Sep 30, 2026 |
| Trevi Therapeutics, Inc. | 414K | US$5.93M | no change | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 230K | US$5.75M | no change | Sep 30, 2026 |
| Edgewise Therapeutics, Inc. | 133K | US$5.4M | no change | Sep 30, 2026 |
| Tandem Diabetes Care, Inc. | 301K | US$4.91M | no change | Sep 30, 2026 |